Quote | Inari Medical Inc. (NASDAQ:NARI)
Last: | $55.21 |
---|---|
Change Percent: | 0.02% |
Open: | $55.78 |
Close: | $55.20 |
High: | $56.095 |
Low: | $54.42 |
Volume: | 363,725 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
News | Inari Medical Inc. (NASDAQ:NARI)
2024-07-18 14:32:10 ET More on Inari Medical Inari Medical: A Touch Of Uncertainty And Overvaluation Inari Medical, Inc. 2024 Q1 - Results - Earnings Call Presentation Inari Medical, Inc. (NARI) Q1 2024 Earnings Call Transcript Inari Medical GAAP EPS of -$0.4...
2024-07-18 11:34:12 ET More on Health Care Select Sector SPDR® Fund ETF: XLV: A Strong Way To Benefit From An Aging And Unhealthy Population XLV: Healthcare Is Ripe For Buying, Despite Patent Cliff XLV: Pivotal Week Of Earnings For Healthcare Stocks BofA...
Message Board Posts | Inari Medical Inc. (NASDAQ:NARI)
Subject | By | Source | When |
---|---|---|---|
NARI Inari Medical Inc | mick | investorshub | 04/30/2023 9:30:22 PM |
znewcar1: $NARI Hod69.36 RH69.79 long play!ML. | znewcar1 | investorshangout | 04/24/2023 5:33:33 PM |
NARI Inari Medical Inc | mick | investorshub | 04/15/2023 3:48:18 PM |
$NARI Inari Medical Inc | mick | investorshub | 02/27/2023 1:08:50 AM |
$NARI Inari Medical Inc | mick | investorshub | 02/21/2023 11:48:22 PM |
News, Short Squeeze, Breakout and More Instantly...
IRVINE, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its second quarter 2024...
SAN FRANCISCO, June 27, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses now . Class Period: Feb. 24, 2022 – Feb. 28, 2024 Lead Plaintiff Deadline: July 12, 2024 Visit...
Hagens Berman Encourages NARI Investors with Substantial Losses to Contact Firm Before July 12, 2024 Deadline San Francisco, California--(Newsfile Corp. - June 26, 2024) - Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses no...